A citation-based method for searching scientific literature

Sarthak Gupta, Mariana J Kaplan. J Clin Invest 2021
Times Cited: 3







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Lipid presentation by the protein C receptor links coagulation with autoimmunity.
Nadine Müller-Calleja, Anne Hollerbach, Jennifer Royce, Svenja Ritter, Denise Pedrosa, Thati Madhusudhan, Sina Teifel, Myriam Meineck, Friederike Häuser, Antje Canisius,[...]. Science 2021
7
33

Interaction of anti-phospholipid antibodies with late endosomes of human endothelial cells.
B Galve-de Rochemonteix, T Kobayashi, C Rosnoblet, M Lindsay, R G Parton, G Reber, E de Maistre, D Wahl, E K Kruithof, J Gruenberg,[...]. Arterioscler Thromb Vasc Biol 2000
57
33

Tissue factor pathway inhibitor primes monocytes for antiphospholipid antibody-induced thrombosis.
Nadine Müller-Calleja, Anne Hollerbach, Svenja Ritter, Denise G Pedrosa, Dennis Strand, Claudine Graf, Christoph Reinhardt, Susanne Strand, Philippe Poncelet, John H Griffin,[...]. Blood 2019
16
33

Factor VIIa induces anti-inflammatory signaling via EPCR and PAR1.
Vijay Kondreddy, Jue Wang, Shiva Keshava, Charles T Esmon, L Vijaya Mohan Rao, Usha R Pendurthi. Blood 2018
18
33

EPCR-dependent PAR2 activation by the blood coagulation initiation complex regulates LPS-triggered interferon responses in mice.
Hai Po H Liang, Edward J Kerschen, Irene Hernandez, Sreemanti Basu, Mark Zogg, Fady Botros, Shuang Jia, Martin J Hessner, John H Griffin, Wolfram Ruf,[...]. Blood 2015
43
33

Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease.
Christian Lood, Stefan Amisten, Birgitta Gullstrand, Andreas Jönsen, Maria Allhorn, Lennart Truedsson, Gunnar Sturfelt, David Erlinge, Anders A Bengtsson. Blood 2010
121
33

Endothelial progenitor dysfunction associates with a type I interferon signature in primary antiphospholipid syndrome.
Robert C Grenn, Srilakshmi Yalavarthi, Alex A Gandhi, Nayef M Kazzaz, Carlos Núñez-Álvarez, Diego Hernández-Ramírez, Antonio R Cabral, W Joseph McCune, Paula L Bockenstedt, Jason S Knight. Ann Rheum Dis 2017
39
33

Diagnosis and Management of the Antiphospholipid Syndrome.
David Garcia, Doruk Erkan. N Engl J Med 2018
188
33


Environmental Triggers of Autoreactive Responses: Induction of Antiphospholipid Antibody Formation.
Anush Martirosyan, Rustam Aminov, Gayane Manukyan. Front Immunol 2019
17
33

Antiphospholipid antibodies induce translocation of TLR7 and TLR8 to the endosome in human monocytes and plasmacytoid dendritic cells.
Nadine Prinz, Natascha Clemens, Dennis Strand, Inge Pütz, Mareike Lorenz, Andreas Daiber, Pamela Stein, Adriana Degreif, Markus Radsak, Hansjörg Schild,[...]. Blood 2011
68
33


Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions.
Yvan Jamilloux, Thomas Henry, Alexandre Belot, Sébastien Viel, Maxime Fauter, Thomas El Jammal, Thierry Walzer, Bruno François, Pascal Sève. Autoimmun Rev 2020
264
33

NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients.
Sunny Malhotra, Carme Costa, Herena Eixarch, Christian W Keller, Lukas Amman, Helios Martínez-Banaclocha, Luciana Midaglia, Eduard Sarró, Isabel Machín-Díaz, Luisa M Villar,[...]. Brain 2020
23
33

Heterogeneity of the cytokinome in undifferentiated arthritis progressing to rheumatoid arthritis and its change in the course of therapy. Move toward personalized medicine.
Edyta Brzustewicz, Izabella Bzoma, Agnieszka Daca, Maria Szarecka, Malgorzata Sochocka Bykowska, Jacek M Witkowski, Ewa Bryl. Cytokine 2017
6
33

'Prototypical' proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting.
Alessandra Musella, Diego Fresegna, Francesca Romana Rizzo, Antonietta Gentile, Francesca De Vito, Silvia Caioli, Livia Guadalupi, Antonio Bruno, Ettore Dolcetti, Fabio Buttari,[...]. Expert Opin Ther Targets 2020
5
33

DAMP-sensing receptors in sterile inflammation and inflammatory diseases.
Tao Gong, Lei Liu, Wei Jiang, Rongbin Zhou. Nat Rev Immunol 2020
221
33

Advanced Multi-Dimensional Cellular Models as Emerging Reality to Reproduce In Vitro the Human Body Complexity.
Giada Bassi, Maria Aurora Grimaudo, Silvia Panseri, Monica Montesi. Int J Mol Sci 2021
2
50


Managing adverse effects of interferon-alfa and ribavirin in combination therapy for HCV.
Jihad Slim, Muhammad Shoaib Afridi. Infect Dis Clin North Am 2012
8
33

The Roles of Inflammasomes in Host Defense against Mycobacterium tuberculosis.
Jialu Ma, Shasha Zhao, Xiao Gao, Rui Wang, Juan Liu, Xiangmei Zhou, Yang Zhou. Pathogens 2021
2
50


IL-1 family cytokines and soluble receptors in systemic lupus erythematosus.
Paola Italiani, Maria Laura Manca, Francesca Angelotti, Daniela Melillo, Federico Pratesi, Ilaria Puxeddu, Diana Boraschi, Paola Migliorini. Arthritis Res Ther 2018
22
33

Human monocyte-derived macrophages inhibit HCMV spread independent of classical antiviral cytokines.
Jennifer Becker, Volker Kinast, Marius Döring, Christoph Lipps, Veronica Duran, Julia Spanier, Pia-Katharina Tegtmeyer, Dagmar Wirth, Luka Cicin-Sain, Antonio Alcamí,[...]. Virulence 2018
6
33


Inflammasome activation and assembly at a glance.
Ankit Malik, Thirumala-Devi Kanneganti. J Cell Sci 2017
146
33

Interleukin-1β Induces mtDNA Release to Activate Innate Immune Signaling via cGAS-STING.
Lauren D Aarreberg, Katharina Esser-Nobis, Connor Driscoll, Andrey Shuvarikov, Justin A Roby, Michael Gale. Mol Cell 2019
56
33

Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.
Kristina Ludigs, Valeriy Parfenov, Renaud A Du Pasquier, Greta Guarda. Cell Mol Life Sci 2012
31
33

Human Cytokinome: a new challenge for systems biology.
Susan Costantini, Giuseppe Castello, Giovanni Colonna. Bioinformation 2010
22
33

Moving towards a systems-based classification of innate immune-mediated diseases.
Sinisa Savic, Emily A Caseley, Michael F McDermott. Nat Rev Rheumatol 2020
18
33

Shared and Distinct Functions of Type I and Type III Interferons.
Helen M Lazear, John W Schoggins, Michael S Diamond. Immunity 2019
230
33

TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis.
Curdin Conrad, Jeremy Di Domizio, Alessio Mylonas, Cyrine Belkhodja, Olivier Demaria, Alexander A Navarini, Anne-Karine Lapointe, Lars E French, Maxime Vernez, Michel Gilliet. Nat Commun 2018
84
33

Inflammasomes, hormesis, and antioxidants in neuroinflammation: Role of NRLP3 in Alzheimer disease.
Manuela Pennisi, Rosalia Crupi, Rosanna Di Paola, Maria Laura Ontario, Rita Bella, Edward J Calabrese, Roberto Crea, Salvatore Cuzzocrea, Vittorio Calabrese. J Neurosci Res 2017
50
33

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood.
Lynda Bennett, A Karolina Palucka, Edsel Arce, Victoria Cantrell, Josef Borvak, Jacques Banchereau, Virginia Pascual. J Exp Med 2003
33

Type I interferon inhibits interleukin-1 production and inflammasome activation.
Greta Guarda, Marion Braun, Francesco Staehli, Aubry Tardivel, Chantal Mattmann, Irmgard Förster, Matthias Farlik, Thomas Decker, Renaud A Du Pasquier, Pedro Romero,[...]. Immunity 2011
591
33

Human eosinophils release IL-1ß and increase expression of IL-17A in activated CD4+ T lymphocytes.
S Esnault, E A B Kelly, L M Nettenstrom, E B Cook, C M Seroogy, N N Jarjour. Clin Exp Allergy 2012
37
33

Genetic Lesions of Type I Interferon Signalling in Human Antiviral Immunity.
Christopher J A Duncan, Richard E Randall, Sophie Hambleton. Trends Genet 2021
5
33

β-Glucan-induced reprogramming of human macrophages inhibits NLRP3 inflammasome activation in cryopyrinopathies.
Giorgio Camilli, Mathieu Bohm, Alícia Corbellini Piffer, Rachel Lavenir, David L Williams, Benedicte Neven, Gilles Grateau, Sophie Georgin-Lavialle, Jessica Quintin. J Clin Invest 2020
6
33

A clinical update on inflammasomopathies.
Hafize Emine Sönmez, Seza Özen. Int Immunol 2017
8
33


The STING-IFN-β-Dependent Axis Is Markedly Low in Patients with Relapsing-Remitting Multiple Sclerosis.
Lars Masanneck, Susann Eichler, Anna Vogelsang, Melanie Korsen, Heinz Wiendl, Thomas Budde, Sven G Meuth. Int J Mol Sci 2020
2
50

IL-1 Inhibitors in the Treatment of Monogenic Periodic Fever Syndromes: From the Past to the Future Perspectives.
Hana Malcova, Zuzana Strizova, Tomas Milota, Ilja Striz, Anna Sediva, Dita Cebecauerova, Rudolf Horvath. Front Immunol 2021
2
50


Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling.
Isabelle Melki, Yoann Rose, Carolina Uggenti, Lien Van Eyck, Marie-Louise Frémond, Naoki Kitabayashi, Gillian I Rice, Emma M Jenkinson, Anaïs Boulai, Nadia Jeremiah,[...]. J Allergy Clin Immunol 2017
80
33

Therapeutic Perspectives for Interferons and Plasmacytoid Dendritic Cells in Rheumatoid Arthritis.
Ramzi Nehmar, Alexandre Mariotte, Aurore de Cauwer, Jean Sibilia, Seiamak Bahram, Philippe Georgel. Trends Mol Med 2018
9
33

Rituximab for the treatment of multiple sclerosis: a review.
Clara Grazia Chisari, Eleonora Sgarlata, Sebastiano Arena, Simona Toscano, Maria Luca, Francesco Patti. J Neurol 2021
8
33

Perception of self: distinguishing autoimmunity from autoinflammation.
Tessa S van Kempen, Mark H Wenink, Emmerik F A Leijten, Timothy R D J Radstake, Marianne Boes. Nat Rev Rheumatol 2015
54
33


Relationship of pain and fatigue with health-related quality of life and work in patients with psoriatic arthritis on TNFi: results of a multi-national real-world study.
P G Conaghan, Rieke Alten, Atul Deodhar, Emma Sullivan, Stuart Blackburn, Haijun Tian, Kunal Gandhi, Steffen M Jugl, Vibeke Strand. RMD Open 2020
5
33

The roles of TLRs, RLRs and NLRs in pathogen recognition.
Taro Kawai, Shizuo Akira. Int Immunol 2009
942
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.